Literature DB >> 3562490

Vinpocetine enhances retrieval of a step-through passive avoidance response in rats.

V J DeNoble.   

Abstract

Vinpocetine, vincamine, apovincaminic acid, vinconate, aniracetam, Hydergine, and pemoline were evaluated for their ability to enhance retrieval of a step-through passive avoidance response in rats. The percentage of rats performing the avoidance response was found to decrease as a function of the number of days between training and retention testing (Day 1, 100%; Day 2, 65%; Day 3, 23%; Days 4 and 5, 0%). Vinpocetine administered 60 minutes prior to testing for retention significantly increased the number of rats performing the passive avoidance response. Retrieval enhancement was dose-related in an inverted U-shaped function with the effective doses at 18 and 30 mg/kg PO. In contrast, apovincaminic acid (1-400 mg/kg PO), vincamine (1-200 mg/kg PO), vinconate (1-200 mg/kg PO), aniracetam (1-300 mg/kg PO), Hydergine (0.1-10 mg/kg PO), and pemoline (1-30 mg/kg PO) were not effective. These data support the view that vinpocetine has cognition-activating abilities as defined in an animal model of memory retrieval.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3562490     DOI: 10.1016/0091-3057(87)90552-1

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  10 in total

1.  Vinpocetine as a potent antiinflammatory agent.

Authors:  Alexandre E Medina
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-21       Impact factor: 11.205

2.  Phosphodiesterase type 1 inhibition improves learning in rats exposed to alcohol during the third trimester equivalent of human gestation.

Authors:  Claudio C Filgueiras; Thomas E Krahe; Alexandre E Medina
Journal:  Neurosci Lett       Date:  2010-02-26       Impact factor: 3.046

3.  Early alcohol exposure disrupts visual cortex plasticity in mice.

Authors:  Crystal L Lantz; Weili Wang; Alexandre E Medina
Journal:  Int J Dev Neurosci       Date:  2012-05-14       Impact factor: 2.457

Review 4.  Inhibition of phosphodiesterases as a strategy to achieve neuroprotection in Huntington's disease.

Authors:  Antonella Cardinale; Francesca R Fusco
Journal:  CNS Neurosci Ther       Date:  2018-03-03       Impact factor: 5.243

Review 5.  Fetal alcohol spectrum disorders and abnormal neuronal plasticity.

Authors:  Alexandre E Medina
Journal:  Neuroscientist       Date:  2011-03-07       Impact factor: 7.519

6.  Therapeutic utility of phosphodiesterase type I inhibitors in neurological conditions.

Authors:  Alexandre E Medina
Journal:  Front Neurosci       Date:  2011-02-18       Impact factor: 4.677

Review 7.  Phosphodiesterases as therapeutic targets for Alzheimer's disease.

Authors:  Ana García-Osta; Mar Cuadrado-Tejedor; Carolina García-Barroso; Julen Oyarzábal; Rafael Franco
Journal:  ACS Chem Neurosci       Date:  2012-10-01       Impact factor: 4.418

Review 8.  Phosphodiesterase Inhibitors as a Therapeutic Approach to Neuroprotection and Repair.

Authors:  Eric P Knott; Mazen Assi; Sudheendra N R Rao; Mousumi Ghosh; Damien D Pearse
Journal:  Int J Mol Sci       Date:  2017-03-24       Impact factor: 5.923

Review 9.  Vinpocetine in the treatment of poststroke cognitive dysfunction: A protocol for systematic review and meta-analysis.

Authors:  Yang Liu; Yanying Yin; Qiao-Li Lu; Ying Dan; Mei-Song Xu; Ge Song; Chen Li
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

10.  Cannabis-induced impairment of learning and memory: effect of different nootropic drugs.

Authors:  Omar M E Abdel-Salam; Neveen A Salem; Marwa El-Sayed El-Shamarka; Noha Al-Said Ahmed; Jihan Seid Hussein; Zakaria A El-Khyat
Journal:  EXCLI J       Date:  2013-03-12       Impact factor: 4.068

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.